![](/img/cover-not-exists.png)
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
Peterson, James T., Stacey, Helen L., MacNair, John E., Li, Jianing, Hartzel, Jonathan S., Sterling, Tina M., Benner, Patrice, Tamms, Gretchen M., Musey, Luwy K.Language:
english
Journal:
Human Vaccines & Immunotherapeutics
DOI:
10.1080/21645515.2018.1532250
Date:
November, 2018
File:
PDF, 1.32 MB
english, 2018